the influence of therapeutic dosages of factor viii , factor ix and immunoglobulin preparations on the proliferative capacity of mitogen-activated lymphocytes from patients with hemophilia or idiopathic thrombocytopenia was investigated .
C0015506
factor viii
C0019069
hemophilia